{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:09:57Z","timestamp":1792188597181,"version":"4.4.0"},"reference-count":61,"publisher":"Media Sphere Publishing House","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vestn. oftal'mol."],"published-print":{"date-parts":[[2022]]},"DOI":"10.17116\/oftalma202213801190","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T14:46:27Z","timestamp":1646232387000},"page":"90","source":"Crossref","is-referenced-by-count":5,"title":["Current view on the issue of insufficient effectiveness of anti-VEGF therapy for age-related macular degeneration"],"prefix":"10.17116","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4530-553X","authenticated-orcid":false,"given":"O.V.","family":"Zaytseva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1038-2746","authenticated-orcid":false,"given":"N.V.","family":"Neroeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1121-4314","authenticated-orcid":false,"given":"T.D.","family":"Okhotsimskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5752-8883","authenticated-orcid":false,"given":"E.V.","family":"Bobykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6743","reference":[{"key":"key-10.17116\/oftalma202213801190-1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S976531"},{"key":"key-10.17116\/oftalma202213801190-2","doi-asserted-by":"publisher","DOI":"10.18008\/1816-5095-2018-4-382-387"},{"key":"key-10.17116\/oftalma202213801190-3","doi-asserted-by":"publisher","DOI":"10.17116\/oftalma2021137051152"},{"key":"key-10.17116\/oftalma202213801190-4","unstructured":"Stone TW, ed. ASRS 2018 Preferences and Trends Membership Survey. Chicago, IL. American Society of Retina Specialists; 2018. Accessed August 29, 2018.  https:\/\/www.asrs.org\/content\/documents\/_2018-pat-survey-results-for-website.pdf"},{"key":"key-10.17116\/oftalma202213801190-5","unstructured":"Zaytseva O, Neroev V, Zhulev Y, Petrakovskaya V, Paleeva A, Trifonova M, Efimenko I. Semantic analysis of patient voice in wet AMD and diabetic retinal disease: Patients\u2019 journey and healthcare experience. Euretina 2021 Virtual Abstracts. Type Free Paper, No. 38"},{"key":"key-10.17116\/oftalma202213801190-6","doi-asserted-by":"publisher","DOI":"10.17116\/oftalma202113702166"},{"key":"key-10.17116\/oftalma202213801190-7","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100906"},{"key":"key-10.17116\/oftalma202213801190-8","unstructured":"Lad EM, Grunwald L, Mettu PS, Serrano NP, Crowell S, Cousins SW. Lesion Morphology on Indocyanine Green Angiography in Age-Related Macular Degeneration with Classic Choroidal Neovascular Membrane: Implications for Response to anti-VEGF Treatment. Invest Ophthalmol Vis Sci. 2012;53(14):5161"},{"key":"key-10.17116\/oftalma202213801190-9","unstructured":"Mettu PS, Crowell S, Shaw J, Grunwald L, Lad EM, Serrano N, Cousins SW. Neovascular Morphology on ICG Angiography Predicts Response to Anti-VEGF Therapy in Eyes with Serous Pigment Epithelial Detachments and Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2012; 53(14):2654"},{"key":"key-10.17116\/oftalma202213801190-10","unstructured":"Serrano NP, Shaw J, Mettu PS, Lad EM, Crowell S, Cousins SW. High-speed Indocyanine Green Angiography In Age Related Macular Degeneration With Fibrovascular Pigment Epithelial Detachments. Invest Ophthalmol Vis Sci. 2012;53(14):1151"},{"key":"key-10.17116\/oftalma202213801190-11","unstructured":"Mettu PS, Allingham MJ, Nicholas PC, Cousins SW. Neovascular Morphology by ICG Angiography and Response to Loading-Dose Anti-VEGF Therapy in Patients with Neovascular AMD. Invest Ophthalmol Vis Sci. 2016; 57(12):No Pagination Specified"},{"key":"key-10.17116\/oftalma202213801190-12","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2017.03.004"},{"key":"key-10.17116\/oftalma202213801190-13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.03.045"},{"key":"key-10.17116\/oftalma202213801190-14","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-002-0505-8"},{"key":"key-10.17116\/oftalma202213801190-15","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-303978"},{"key":"key-10.17116\/oftalma202213801190-16","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2007.07.004"},{"key":"key-10.17116\/oftalma202213801190-17","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-199616030-00001"},{"key":"key-10.17116\/oftalma202213801190-18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.08.020"},{"key":"key-10.17116\/oftalma202213801190-19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.10.019"},{"key":"key-10.17116\/oftalma202213801190-20","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-008-0905-5"},{"key":"key-10.17116\/oftalma202213801190-21","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.118760"},{"key":"key-10.17116\/oftalma202213801190-22","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2010.05.003"},{"key":"key-10.17116\/oftalma202213801190-23","unstructured":"Espinosa-Heidmann DG, Suner I, Hernandez EP, Frazier WD, Csaky KG, Cousins SW. Age as an independent risk factor for severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2002;43(5): 1567-1573"},{"key":"key-10.17116\/oftalma202213801190-24","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-12546"},{"key":"key-10.17116\/oftalma202213801190-25","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20049"},{"key":"key-10.17116\/oftalma202213801190-26","unstructured":"Kent D, Sheridan C. Choroidal neovascularization: a wound healing perspective. Mol Vis. 2003;9:747-755"},{"key":"key-10.17116\/oftalma202213801190-27","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(14)72158-0"},{"key":"key-10.17116\/oftalma202213801190-28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.03.018"},{"key":"key-10.17116\/oftalma202213801190-29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092821"},{"key":"key-10.17116\/oftalma202213801190-30","unstructured":"Mettu PS, Saloupis P, Cousins SW. PAMP Stimulation of Macrophages Promotes Neovascular Remodeling in Experimental Choroidal Neovascularization. Invest Ophthalmol Vis Sci. 2014;55(13):1198"},{"key":"key-10.17116\/oftalma202213801190-31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107063"},{"key":"key-10.17116\/oftalma202213801190-32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddstr.2008.11.003"},{"key":"key-10.17116\/oftalma202213801190-33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2005.02.003"},{"key":"key-10.17116\/oftalma202213801190-34","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1985.01050050100026"},{"key":"key-10.17116\/oftalma202213801190-35","doi-asserted-by":"publisher","DOI":"10.1038\/nri3459"},{"key":"key-10.17116\/oftalma202213801190-36","unstructured":"Budzinskaya MV, Gurova IV, Schegoleva IV, Loschenov VB, Shevchik SA, Kuzjmin SG, Vorogtsov GN. Combined modality therapy for exsudative form of age-related macular degeneration. Photodynamic Therapy and Photodyagnosis = Fotodinamicheskaya terapiya i fotodiagnostika. 2013;2(1):20-24 (In Russ.)"},{"key":"key-10.17116\/oftalma202213801190-37","doi-asserted-by":"publisher","DOI":"10.21516\/2072-0076-2021-14-4-137-148"},{"key":"key-10.17116\/oftalma202213801190-38","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.4030"},{"key":"key-10.17116\/oftalma202213801190-39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.02.027"},{"key":"key-10.17116\/oftalma202213801190-40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI74527"},{"key":"key-10.17116\/oftalma202213801190-41","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2019.1667333"},{"key":"key-10.17116\/oftalma202213801190-42","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2019.10.008"},{"key":"key-10.17116\/oftalma202213801190-43","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2017.04.004"},{"key":"key-10.17116\/oftalma202213801190-44","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1636031"},{"key":"key-10.17116\/oftalma202213801190-45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.11.018"},{"key":"key-10.17116\/oftalma202213801190-46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.04.017"},{"key":"key-10.17116\/oftalma202213801190-47","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2004.10.005"},{"key":"key-10.17116\/oftalma202213801190-48","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2005.01.013"},{"key":"key-10.17116\/oftalma202213801190-49","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-015-3094-z"},{"key":"key-10.17116\/oftalma202213801190-50","unstructured":"Allingham MJ, Mettu PS, Cousins, SW. Elamipretide, a Mitochondrial-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with High Risk Drusen: Results of the Phase 1 ReCLAIM Study. Invest Ophthalmol Vis Sci. 2019;60(9):361"},{"key":"key-10.17116\/oftalma202213801190-51","unstructured":"Cousins SW, Allingham MJ, Mettu PS. Elamipretide, a Mitochondria-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with Noncentral Geographic Atrophy: Results of the Phase 1 ReCLAIM Study. Invest Ophthalmol Vis Sci. 2019;60(9):974"},{"key":"key-10.17116\/oftalma202213801190-52","unstructured":"Mettu PS, Allingham MJ, Cousins SW. Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study. Invest Ophthalmol Vis Sci. 2019;60(9):358"},{"key":"key-10.17116\/oftalma202213801190-53","doi-asserted-by":"publisher","DOI":"10.34922\/AE.2021.34.6.002"},{"key":"key-10.17116\/oftalma202213801190-54","doi-asserted-by":"publisher","DOI":"10.1177\/1120672120915685"},{"key":"key-10.17116\/oftalma202213801190-55","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2021.1660"},{"key":"key-10.17116\/oftalma202213801190-56","unstructured":"Mon\u00e9s J. Non-responders neovascular AMD concept and spectrum. Presentation at the EURETINA 2021 Virtual (Instructional Course 8: Non-Responders in Neovascular AMD, 09.09.2021)"},{"key":"key-10.17116\/oftalma202213801190-57","unstructured":"FDA Approves Genentech\u2019s Port Delivery System, Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet AMD. Accessed October 26, 2021.  https:\/\/eyewire.news\/news\/fda-approves-genentechs-port-delivery-system-susvimo-a-first-of-its-kind-therapeutic-approach-for-wet-amd"},{"key":"key-10.17116\/oftalma202213801190-58","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002713"},{"key":"key-10.17116\/oftalma202213801190-59","doi-asserted-by":"publisher","DOI":"10.1007\/s11673-011-9293-3"},{"key":"key-10.17116\/oftalma202213801190-60","unstructured":"The Royal College of Ophthalmologists. Age-related macular degeneration: guidelines for management. September 2013. Accessed October 21, 2021.  https:\/\/www.rcophth.ac.uk\/wp-content\/uploads\/2014\/12\/2013-SCI-318-RCOphth-AMD-Guidelines-Sept-2013-FINAL-2.pdf"},{"key":"key-10.17116\/oftalma202213801190-61","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0747-x"}],"container-title":["Vestnik oftal'mologii"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T14:56:12Z","timestamp":1646232972000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/vestnik-oftalmologii\/2022\/1\/10042465X2022011090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"alternative-id":["10.17116\/oftalma202213801190"],"URL":"https:\/\/doi.org\/10.17116\/oftalma202213801190","relation":{},"ISSN":["0042-465X"],"issn-type":[{"value":"0042-465X","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}